Immune senescence: A key player in cancer biology.
Abstract
With the rapid development of immunological techniques in recent years, our understanding of immune senescence has gradually deepened, but the role of immune senescence in cancer biology remains incompletely elucidated. Understanding these mechanisms and interactions is crucial for the development of tumor biology. This review examines five key areas: the classification and main features of immune senescence, factors influencing immune cell senescence in cancer, the reciprocal causal cycle between immune senescence and malignancy, and the potential of immune senescence as a target for cancer immunotherapy.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper discusses immune senescence and its role in cancer biology, which is relevant to aging research as it explores mechanisms that could be linked to age-related decline in immune function. However, it primarily focuses on cancer treatment rather than addressing the root causes of aging or lifespan extension. The impact is solid but limited, as it provides a review of existing knowledge rather than presenting new experimental findings or breakthroughs.
Author of this paper? Send a correction.